Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 246 of 1,261
  1. US 11414496

    Anti-CD38 binding domains

    Takeda Pharmaceutical Company Limited · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  2. US 11414657

    Modified CRISPR RNA and modified single CRISPR RNA and uses thereof

    Ionis Pharmaceuticals, Inc. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  3. US 11413278

    Compounds and methods for promoting stress resistance

    The Regents of the University of California · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  4. US 11414458

    Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies

    The Board of Regents of the University of Oklahoma · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  5. US 11414379

    SPAK kinase inhibitors as neuroprotective agents

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  6. US 11413303

    Methods for treatment of arthritis

    GALECTIN THERAPEUTICS, INC. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  7. US 11413274

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  8. US 11413350

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted
  9. US 11406713

    Xanthine oxidase inhibitor formulations

    XORTX THERAPEUTICS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  10. US 11406646

    Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  11. US 11407822

    Treatment of fibrodysplasia ossificans progressiva

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  12. US 11407789

    Cell-penetrating compstatin analogs and uses thereof

    Apellis Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  13. US 11407723

    Selective histone deacetylase inhibitors for the treatment of human disease

    Shuttle Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  14. US 11406716

    Modified RNAi agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  15. US 11406656

    Methods and compositions for administration of iron

    American Regent, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  16. US 11406618

    Polymer-des-ethyl sunitinib conjugates

    Nektar Therapeutics · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  17. US 11407997

    Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders

    CRISPR THERAPEUTICS AG · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  18. US 11407998

    Twist signaling inhibitor compositions and methods of using the same

    The Regents of the University of California · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  19. US 11407825

    NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  20. US 11408001

    Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  21. US 11407990

    Fusion proteins and methods for site-directed genome editing

    The Regents of the University of California · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  22. US 11407984

    Methods for purification of arysulfatase A

    Takeda Pharmaceutical Company Limited · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  23. US 11407818

    Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted
  24. US 11407813

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.